Intra Cellular Therapies | Salg



Sales Endring Dato
Acadia Pharmaceuticals USD 259.6M 9.2M 2024-12
ALKERMES USD 430M 51.9M 2024-12
Biogen USD 2.45B 11.1M 2024-12
Bristol-Myers Squibb USD 12.34B 450M 2024-12
Cytokinetics USD 16.93M 16.46M 2024-12
Gilead Sciences USD 7.57B 24M 2024-12
Halozyme Therapeutics USD 298.01M 7.92M 2024-12
Intra Cellular Therapies USD 199.22M 23.85M 2024-12
J&J USD 22.52B 49M 2024-12
Neurocrine Biosciences USD 627.7M 5.6M 2024-12
Novartis USD 13.56B 386M 2024-12
Prothena USD 2.12M 1.15M 2024-12
RedHill Biopharma USD 1.29M 722K 2024-06
Supernus Pharmaceuticals USD 174.16M 1.53M 2024-12
United Therapeutics USD 735.9M 13M 2024-12



Intra Cellular Therapies Salg - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2025.